Neurotrophins (NTs) control neuron survival and regeneration. Recent research showed that NTs possess cardiovascular actions. In this study, we investigated the hypothesis that the NT nerve growth factor (NGF) prevents cardiomyocyte apoptosis. We demonstrated that cultured rat neonatal cardiomyocytes (RNCMs) produce NGF and express its trkA (tropomyosin-related receptor A (NGF high-affinity receptor)) receptor. RNCMs given a neutralizing antibody for NGF or the trkA inhibitor K252a underwent apoptosis, thus suggesting that NGF is an endogenous prosurvival factor for cardiomyocytes. Adenovirus (Ad)-mediated NGF overexpression protected RNCMs from apoptosis induced by either hypoxia/reoxygenation or angiotensin II (AngII). Similarly, recombinant NGF inhibited AngII-induced apoptosis in isolated rat adult cardiomyocytes. Finally, in a rat model of myocardial infarction, NGF gene transfer promoted cardiomyocyte survival. In RNCMs, recombinant NGF induced trkA phosphorylation, followed by Ser473 phosphorylation and nuclear translocation of phospho-protein kinase B (Akt). In response to Akt activation, Forkhead transcription factors Foxo-3a and Foxo-1 were phosphorylated and excluded from the nucleus. The prosurvival effect of adenoviral vector carrying the human NGF gene was inhibited in vitro by K252a, LY294002 (a panphosphatidyl inositol 3-kinase -PI3K -inhibitor), an Akt small interfering RNA, and adenoviruses carrying a dominant negative mutant form of Akt (Ad.DN.Akt) or an Akt-resistant Foxo-3a (Ad. . These results newly demonstrate the cardiac prosurvival action of NGF and provide mechanistic information on the signaling pathway, which encompasses trkA, PI3K-Akt, and Foxo. Neurotrophins (NTs) were initially considered for their prosurvival and regenerative actions on the nervous system. These beneficial actions of NTs are mediated by their tropomyosin-related kinase receptors (trks), which are tyrosin kinases.
Neurotrophins (NTs) were initially considered for their prosurvival and regenerative actions on the nervous system. These beneficial actions of NTs are mediated by their tropomyosin-related kinase receptors (trks), which are tyrosin kinases. 1, 2 Recent studies have unraveled the potential of nerve growth factor (NGF) and other NTs for vascular biology. [3] [4] [5] [6] [7] Our group discovered that NGF protects endothelial cells and skeletal myocytes from apoptosis and promotes neovascularization in murine ischemic limb muscles and diabetic skin wounds. 3, 5, 6 We demonstrated the involvement of protein kinase B (Akt) in NGF-induced angiogenesis. 3 Although others already tracked the presence of NGF in the heart and isolated cardiomyocytes, [8] [9] [10] [11] the hypothesis that NGF controls cardiomyocyte survival was, to the best of our knowledge, never investigated.
In noncardiovascular cells, NGF, via Akt, promotes the nuclear exclusion of Foxo-3a and Foxo-1, two members of the Forkhead box, class O (Foxo) subfamily of Forkhead transcription factors, which stimulate cell death. 12 Nuclear localization of Foxo activates several Foxo-responsive genes, including the proapoptotic TNFa, Fas ligand, and Bim. [13] [14] [15] [16] Akt-dependent Foxo phosphorylation inactivates the Foxo nuclear translocation signal and promotes the interaction of Foxo with 14-3-3 proteins, thus keeping Foxo out of the nucleus. In the cytosol, Akt-phosphorylated Foxo is targeted for proteasomal degradation. 14 Interestingly, Skurk et al. 17 reported the presence of an Akt/ Forkhead signaling axis in cardiomyocytes in vitro and in vivo and Morris et al. 18 showed that overexpression of Foxo-1 in the cardiomyocyte nucleus activates the transcription of the proapoptotic factor TNFa-related apoptosis-inducing ligand (TRAIL).
Here we report the discovery that NGF is an endogenous prosurvival factor for the cardiomyocyte and describe the NGF antiapoptotic pathway. This is initiated by the NGF highaffinity receptor trkA (tropomyosin-related receptor A (NGF high affinity receptor)) and involves the nuclear/cytoplasmatic shuttling of Akt, Foxo-3a, and Foxo-1. Moreover, we demonstrate that NGF gene transfer into the rat infarcted heart prevents cardiomyocyte apoptosis, thus providing evidence that the prosurvival effect of this NT may have a potential for cardiac protection.
cardiomyocyte may be a target of the NGF action was, to the best of our knowledge, never proposed.
In this study, we confirmed the expression of NGF in rat neonatal cardiomyocytes (RNCMs) by immunocytochemistry ( Figure 1a ) and RT-PCR (Figure 1b ). In addition, by ELISA, we detected NGF in the serum-free conditioned culture media (CCM) of RNCMs (Figure 1d) . Moreover, as shown in Figure 1e , the CCM of RNCMs promoted neurite outgrowth from PC12 cells (PC12), an action that is reportedly mediated by NGF. 9 Consistently, a neutralizing antibody for NGF (Ab-NGF, goat polyclonal, 1 mg/ml) 3 prevented the effect of CCM on PC12 differentiation. Finally, by RT-PCR and western blot, we showed that RNCMs express the trkA receptor of NGF (Figure 1b and c). Altogether, these results indicate that RNCMs not only produce and release functionally competent NGF but are also equipped to respond to NGF.
An autocrine mechanism mediates the prosurvival action of NGF. RNCMs reportedly undergo apoptotic cell death following hypoxia/reoxygenation (H/R) 19 or stimulation with angiotensin II (AngII). 20 We examined whether stressed RNCMs release NGF for self-protection. To this aim, serum-free-maintained RNCMs were submitted to 12 h hypoxia followed by 24 h reoxygenation (H/R) or were stimulated with AngII (10 À7 M) for 24 h. As shown by Figure 2a , the content of NGF in the CCM of RNCMs increased under both conditions. We then asked whether endogenous NGF, via trkA, promotes cardiomyocyte survival in an autocrine way. To this aim, serum-free-cultured RNCMs were incubated for 48 h in the presence of Ab-NGF or K252a (100 nM), an inhibitor of trkA. 21 Controls received nonimmune goat serum (0.1% in PBS) or 0.1% DMSO. Blocking experiments were also performed on RNCMs under H/R or AngII treatments. To this aim, Ab-NGF, K252a, and the respective controls were added 30 min before starting H/R or incubation with AngII. Since caspase activation is implicated in the initiation as well as execution of the apoptotic program triggered by diverse signals, 22 we stained our culture for cleaved (activated) caspase-3 to detect apoptotic cell death. The percentage of cleaved capase-3-positive apoptotic RNCMs was calculated. As shown in Figure 2b and c, blockade of NGF or its receptor led to increased RNCM apoptosis and also enhanced the proapoptotic effect of H/R or AngII, thus suggesting the presence of an autocrine NGF-driven signaling, instrumental to cardiomyocyte survival. Results were confirmed by terminal deoxy-nucleotideyltransferase-mediated dUTP nick end-labeling (TUNEL) assay (data not shown).
NGF signaling in RNCMs. In order to identify the prosurvival signaling mechanism initiated by NGF in cardiomyocytes, serum-free-cultured RNCMs were stimulated with recombinant NGF (50 ng/ml) for 10, 20, or 60 min. As shown in Figure 3a , NGF supported the phosphorylation of trkA (in Tyr490, active form), Akt (in Ser473, active form), Foxo-3a (in Thr32, inactive form), and Foxo-1 (in Ser256, inactive form). The phosphorylation of trkA and Akt peaked at 20 min from NGF addition and returned to the basal level by 60 min, whereas the phosphorylation of both Foxo-3a and Foxo-1 was maximal at 60 min. In separate experiments, 30 min before NGF, RNCMs were pretreated with K252a (100 nM), the PI3K inhibitor LY294002 (50mM), or vehicle (0.1% DMSO). As shown in Figure 3b , K252a completely prevented Akt phosphorylation, thus suggesting that trkA mediates NGFinduced Akt activation. As shown in Figure 3c , LY294002 prevented the phosphorylation of Akt, Foxo-3a, and Foxo-1 in response to NGF, thus suggesting that NGF controls Foxo through PI3K-Akt.
Next, we investigated whether the Akt/Foxo pathway is activated by endogenous NGF. To this aim, RNCMs were incubated with Ab-NGF or K252a (or the respective controls) for 48 h in serum-free medium. Cells were then lysated to perform western blot analyses of Ser473-phospho-Akt, Thr32-phospo-Foxo-3a, Ser256-phospho-Foxo-1, and the respective total forms. As shown in Figure 3d , both Ab-NGF and K252a impaired the phosphorylation of Akt, Foxo-3A, and Foxo-1.
NGF induces the nuclear/cytoplasmic shuttling of phospho-Akt and Foxo in RNCMs. We then evaluated the effect of NGF on the intracellular compartmentalization of Akt and Foxo. Serum-free-cultured RNCMs were given LY294002 or vehicle 30 min before adding NGF (50 ng/ml) or PBS control. After 20 min, RNCMs were fixed and stained for phospho-Akt, total Foxo-3a, or total Foxo-1. As illustrated in Figure 4a , under conditions of serum starvation, control RNCMs showed predominant nuclear localization of Foxo-3a and Foxo-1, while phospho-Akt was mainly expressed in the cytosol. NGF-stimulated RNCMs showed an inverse pattern, with phospho-Akt being mainly located in the nucleus and Foxo-3a and Foxo-1 in the cytosol. PI3K inhibition by LY294002 prevented NGF-induced effect on Akt and Foxo localization. The finding that NGF promotes the nuclear accumulation of active phospho-Akt and the nuclear exclusion of both Foxo-3A and Foxo-1 was confirmed by western blot analyses on cytosolic and nuclear fractions (Figure 4b ).
Ad.NGF increases the phosphorylation of Akt, Foxo-3a, and Foxo-1. We then evaluated the effect of prolonged NGF overexpression, which was achieved by means of adenovirus (Ad)-mediated NGF gene transfer, on Akt and Foxo phosphorylation. Successful adenovirus-mediated transduction of RNCMs using adenoviral vector carrying the human NGF gene (Ad.NGF) (carrying a V5-tag, 50 M.O.I.) was confirmed by RT-PCR, using primers that specifically amplify human but not rat NGF cDNA (Supplementary Figure  S1a) . Transgene expression was not affected by either H/R, or incubation with AngII (Supplementary Figure S1a) . Furthermore, western blot analyses using an antibody anti-V5 tag performed on both RNCM cell lysates and the RNCM serum-free CCM confirmed successful transgene expression (Supplementary Figure S1b) . Neither H/R, nor AngII interfered with transgene expression at the protein level (Supplementary Figure S1b) .
Next, by ELISA, we measured 47-fold higher concentration of NGF in the CCM of NGF-transduced RNCMs, as compared with the CCM of b-Gal-transduced RNCMs (Supplementary Figure S1c) . NGF gene transfer promoted phosphorylation of Akt, Foxo-1, and Foxo-3a in cardiomyocytes (Supplementary Figure S1d) . This pattern of phosphorylation is consistent with that observed after stimulation with recombinant NGF.
NGF gene transfer inhibits apoptosis of RNCMs. In order to demonstrate that NGF strengthens the resistance of cardiomyocytes to stress, we performed two different apoptotic assays on cultured RNCMs. Both cleaved (activated) caspase-3 staining (Figure 5a ) and TUNEL assay (Supplementary Figure S2a) of PBS-treated wells showed that the number of apoptotic RNCMs increases following H/R and that Ad.NGF reduces H/R-induced apoptosis. We additionally examined the effect of Ad.NGF on AngII-induced apoptosis. To this aim, RNCMs were incubated with AngII (10 À7 M) for 24 h before determining apoptosis by both cleaved caspase-3 staining (Figure 5b ) and TUNEL assay (Supplementary Figure S2b) . In both cases, we found that Ad.NGF protects cardiomyocytes from AngII-induced apoptosis.
Mechanism of NGF-induced RNCM survival. We then asked whether the trkA/PI3K/Akt/Foxo pathway is NGF inhibits AngII-mediated apoptosis of rat adult myocytes. Next, we tested whether the antiapoptotic action of NGF expands to adult cardiomyocytes. Cardiac myocytes were extracted from the heart of adult Wistar rat and treated with AngII (10 À9 M) for 24 h (according to Kajstura et al.) 23 or submitted to 6 h hypoxia/18 h reoxygenation (according to Kang et al.) 24 in the presence of recombinant NGF (50 ng/ml) or PBS. TUNEL assay showed that NGF partially prevented apoptosis induced by Figure 4 NGF induces nuclear/cytoplasmatic shuttling of phospho-Akt and Foxo-3a and Foxo-1 in RNCMs. (a) Serum-starved RNCMs were pretreated with LY294002 or its vehicle (0.1% DMSO) before receiving NGF (50 ng/ml) or PBS. After 20 min, cells were fixed and stained for phospho-Akt, total Foxo-3a, or total Foxo-1 by using FITCconjugated antibodies (green fluorescence). Nuclei were stained by PI (red fluorescence). Exposure was optimized to demonstrate localization and it does not reflect the concentration of the antigen. NGF induced nuclear localization of phospho-Akt (as demonstrated by the yellow/orange colors of nuclei, which indicates colocalization of FITC and PI) and promoted nuclear export of Foxo-3a and Foxo-1. LY294002 abolished these NGF effects. Graphs show the percentage of RNCMs expressing nuclear phosphoAkt, Foxo-3a, and Foxo-1. Results are from three independent experiments. Data are presented as mean7S.E.M. (n ¼ 3). *Po0.05 and **Po0.01 versus PBS; y Po0.05 versus NGF þ 0.1% DMSO (NGF). (b) Serum-starved RNCMs were pretreated with LY294002 or its vehicle (0.1% DMSO) for 30 min before receiving NGF (50 ng/ml) or PBS. After 20 min, cells were lysated and nuclear and cytoplasmatic fraction prepared. Nuclear and cytoplasmatic extracts were assessed by western blot using antibodies targeting phospho-and total form of Akt, Foxo-3a, and Foxo-1. Efficient separation of nuclear and cytoplasmatic fractions was confirmed by western blot for histone H3 and a-sarcomeric actin, respectively Intra-myocardial NGF gene transfer reduces myocyte apoptosis in the rat infarcted heart. Myocardial infarction (MI) triggers cardiomyocyte apoptosis. Following an immediate massive apoptosis response to coronary occlusion, later cardiomyocyte apoptosis manifests in the peri-infarct myocardium and eventually contributes to maladaptative post-MI ventricular remodeling and progression towards heart failure. [25] [26] [27] [28] We further investigated the prosurvival role of NGF in a rat model of MI induced by permanent coronary ligation. To this specific aim, we injected Ad.NGF or the control Ad.bGal in the periinfarct myocardium. Successful gene transfer was confirmed (at 3 days post-MI and gene delivery) by RT-PCR using primers that specifically amplify human but not rat NGF cDNA (data not shown). Moreover, at 7 days from gene delivery, transverse sections of the left ventricle were prepared from diastole-arrested and perfusion/fixed hearts. Immunohistochemistry for V5 showed the presence of V5 in the injected myocardium (Supplementary Figure S6) . Only a fraction of cardiomyocytes stained positive for V5. However, it must be considered that NGF is secreted to act extracellularly on its trkA receptor. Therefore, nontransduced cardiomyocytes could still benefit of transgenic NGF. Moreover, transgene expression may be higher at earlier time points. Having validated the gene transfer procedure, we next examined the effect of intramyocardial Ad.NGF on cardiomyocyte apoptosis. On sections cut from the same hearts of above, apoptotic cardiomyocytes were revealed by double staining for TUNEL and the specific cardiac marker a-sarcomeric actin and counted in the peri-infarct myocardium. As shown by Figure 8 , Ad.NGF reduced the percentage of TUNELpositive apoptotic cardiomyocytes (*Po0.05 versus Ad.bGal ).
Discussion
NTs were christened in consideration of their actions on the nervous system and, for a long time, they were exclusive interest of neuroscientists. This family of polypeptides was known to promote the survival and regeneration of neurons, but the possibility that the cardiac muscle may be a direct target of NTs was never investigated before. In fact, even those scientists who found NGF expressed by the myocardium interpreted their findings as a modulation by the cardiomyocyte of its innervation, 9 while ignoring the possibility that cardiomyocytes could release NGF in response to and for their own protection from stress.
During the last 10 years, the relevance of NTs in the regulation of cardiovascular function has been demonstrated by us and others, including the capacity of NGF to promote angiogenesis and prevent endothelial cell apoptosis. [3] [4] [5] [6] Hereby, we report for the fist time that NGF posses a direct antiapoptotic effect on the cardiomyocyte and describe the underlying signaling mechanism. These results were obtained using different experimental models, which expand from cultured rat neonatal and adult cardiomyocytes to an in vivo rat model of myocardial infarction.
We identified the prosurvival pathway of NGF by working on cultured RNCMs. We found that those cells produce and release NGF in a stress-regulated manner and express the trkA receptor, which binds NGF with high affinity. Upon addition of recombinant NGF to RNCMs, trkA is phosphorylated and, via PI3K, it activates Akt. Active phospho-Akt disrupts the action of Foxo-3a and Foxo-1 by phosphorylation, which is a prerequisite for the nuclear exclusion and consequent inactivation of Foxo.
14 By both immunocytochemistry and western blot analyses of nucleus and cytosolic fractions, we demonstrate that NGF promotes the nuclear accumulation of phospho-Akt and the nuclear exclusion of Foxo-3a and Foxo-1. Notably, we also found that the Akt/Foxo axis can be directly activated by NGF produced by RNCMs, as an autocrine mechanism instrumental to survival. In fact, when we neutralized NGF or blocked its receptor trkA, the levels of both phosphorylated (active) Akt and phosphorylated (inactive) Foxo significantly decreased, while apoptosis increased. Furthermore, apoptosis induced by both H/R and AngII was exacerbated by blocking the endogenous NGF/trkA system. The complex of these findings poses the fundaments for a key role of NGF in cardiac physiology.
In previous publications, we and Cantarella et al. 4 showed that Akt mediates NGF-induced angiogenesis. 3 In addition, others published on the prosurvival role of the NGF/Akt axis in neuronal cells. 29 The antiapoptotic role of Akt in the heart is matter of great attention, as reviewed recently by Catalucci and Condorelli. 30 Our findings show an additional factor which can impact on this signaling pathway for the control of cardiomyocyte fate.
Apoptosis contributes to cardiac dysfunction in coronary heart disease as well as in idiopathic cardiomyopathy. Not many remedies to combat apoptosis are clinically available. Consequently, the identification of factors able to counteract cardiomyocyte apoptosis is important and may help in establishing new strategies for prevention of heart failure. We reasoned that, since cardiomyocytes release NGF for their own protection, this mechanism could be amplified for therapeutic purposes. Overexpression of NGF led to activation of Akt/Foxo pathway and endowed RNCMs with resistance from hypoxia/reoxygenation or AngII-induced apoptosis, as documented by both immunostaining for activated caspase-3 and TUNEL assay. Supplementation of recombinant NGF to rat adult cardiomyocytes exerted similar protective effects, suggesting that the NT is equally effective in mature cardiac cells.
As a final proof of concept, we aimed to demonstrate the prosurvival action of NGF in vivo. To this aim, we injected the human NGF gene into the rat peri-infarct myocardium, the area that typically shows high levels of cardiomyocyte apoptosis. [25] [26] [27] [28] [29] Results indicate the successful transduction of rat heart with the transgene and, most importantly, the benefit for cardiomyocyte survival in the peri-infarct myocardium. The in vivo cardiac effect of NGF may be attributable to both direct and indirect actions. In fact, similarly to what already seen in limb muscles, 3, 5 NGF proved to promote myocardial neovascularization (Meloni and Emanueli, unpublished results, 2005), which may account for a better perfusion and improved delivery of oxygen and nutrients to the infarctspared myocytes.
In conclusion, we demonstrated that NGF directly targets the cardiomyocyte and promote its survival. Our discovery Figure 8 Local NGF gene transfer prevents apoptosis of cardiomyocytes in the rat infarcted heart. Myocardial infarction (MI) was induced in adult Wistar rat. Ad.NGF or Ad.bGal (each at 10 8 p.f.u.) was injected in the peri-infarct myocardium. After 7 days, the heart was arrested in diastole and perfusion/fixed. Apoptosis of cardiomyocytes (CMs) was revealed by double staining for TUNEL (TUNEL-positive nuclei are stained in dark brown) and the cardiac marker a-sarcomeric actin (in purple). Nuclei were counterstained with hematoxylin. In the pictures captured (optical microscopy, Â 1000) from Ad.NGF and Ad.bGal specimens, TUNEL-positive apoptotic cardiomyocytes are pointed by arrows. Graph quantifies apoptosis of cardiomyocytes per mm 2 of peri-infarct myocardium section. Values are mean7S.E.M. (n ¼ 7) *Po0.05 versus Ad.bGal implicates NGF as a possible therapeutic agent for the cure of degenerative heart disease and also encourages research aimed at unraveling the prosurvival action of other NTs on cardiovascular cells.
Materials and Methods RNCM culture. All the procedures involving laboratory animals conform to the Guide for the Care and the Use of Laboratory Animals published by the US National Institute of Health (NIH publication No. 85-23, revised 1996), the guidelines and regulations of the University of Bristol and the United Kingdom Home Office, and of the University of Parma and the Italian Minister of Health. RNCMs were isolated from 2-to 3-day-old Wistar rats (bred at the University of Bristol), as previously described. 31 Cardiomyocytes were seeded on gelatin-coated plates and maintained in 4 : 1 DMEM-M199 serum-free medium. The level of purity of RNCM cultures was routinely assessed by staining for the cardiac marker a-sarcomeric actin.
Isolation of rat adult cardiomyocytes. Wistar rats (Charles River, Margate, UK) were anesthetized and heparinized and their hearts were rapidly excised and hung in a Langhendorff apparatus. Isolated cells were obtained by collagenase perfusion of the heart, as previously described. 32 Cardiomyocytes were plated on laminin-precoated two-well chamber slides and maintained in M199 serum-free medium.
RNA extraction and RT-PCR. Total RNA of RNCMs was extracted using RNAesy mini kit (Qiagen, Valencia, CA, USA). First-strand cDNA was synthesized from 1 mg of total RNA using 200 U of Moloney-murine leukemia virus reverse transcriptase (Invitrogen Ltd, Paisley, UK) and oligo-dT oligomer (Invitrogen) as primer. One microliter of each cDNA preparation was amplified by PCR using the following set of primers: rat NGF-b, forward, Western blot analyses. Western blot analyses were carried out as described. 3, 33 The equivalent of 50 mg of proteins (with the exception of 30 mg of proteins for western blot analyses of nuclear and cytosolic RNCM fractions) was loaded on each lane, resolved by SDS-PAGE and transferred to a nitrocellulose membrane (Amersham Bioscience, Piscataway, NJ, USA). Primary antibodies were for Akt, phospho-Akt (Ser 473), Foxo-1, Foxo-3a (all from Cell Signaling, Danvers, MA, USA; 1 : 1000), phospho-Foxo-1 (Ser256) and phospho-Foxo-3a (Thr32) (both from Upstate, Chandelers, Ford, UK; 1 : 500), trkA (1 : 1000, donated by Dr. Dawbarn), phospho trkA (Tyr490) (Calbiochem, San Diego, CA, USA; 1 : 500), a/b tubulin (Cell Signaling 1 : 1000), V5 epitope tag (Novus Biologicals, Littleton, CO, USA, 1 : 5000), histone H3 (Lake Placid Biologicals, Lake Placid, NY, USA, 1 : 5000), and a-sarcomeric actin (DAKO, Ely, UK; 1 : 500). Secondary antibodies were: anti-rabbit, anti-mouse, or anti-goat IgG-horseradish peroxidase conjugate (Amersham Bioscience; 1 : 5000).
ELISA for NGF on the RNMCs conditioned medium. RNCMs were maintained in serum-free medium for 24 h and their conditioned medium was collected and assayed for NGF by ELISA (NGF E max s ImmunoAssay Systems, Promega, Southampton, UK).
Differentiation of PC12 cells. PC12 were stimulated with the RNCM conditioned medium for 3 days and their morphology was examined under a phasecontrast microscopy. The number of differentiated PC12 was counted in five randomly select fields. The criterion for distinguishing differentiated from undifferentiated PC12 was neurite outgrowth greater in length than two cell-body diameters. ) were lysated and cytoplasmic and nuclear extracts were prepared according to the instructions of the NE-PER s nuclear and cytoplasmic extraction kit (Pierce, Rockford, IL, USA).
Preparation of NGF adenovirus. A pCMV-Sport 6 containing the complete cDNA of human NGFb (p.NGF), cloned into NotI and SalI restriction sites, was purchased (LGC Promochem, Teddington, UK). To prepare an adenoviral vector carrying human NGF-b (Ad.NGF), the coding sequence for the NGF-b from p.NGF was amplified (KOD proofreading DNA polymerase, Novagen, San Diego, CA, USA) using primers GCTAGCGTAATGTCCATGTTGTTCTAC (NheI site) and GGATCCTCTCACAGCCTTCCT (BamHI site and stop signal removed) to allow the inclusion of a V5 tag at the C-terminus. The fragment was excised and subcloned in the shuttle vector pDC515 (Microbix Biosystems, Toronto, Canada) modified to contain the V5 coding sequence. A replication-deficient adenovirus was generated by site-specific FLP-mediated recombination of the cotransfected shuttle and genomic plasmids in 293 cells. Viral stocks were amplified, CsCl banded, and titrated. 31 NGF gene transfer to cultured RNCMs. RNCMs were grown in 4:1 DMEM-M199 and were infected overnight with Ad.hNGF or Ad.bGal (each at 50 M.O.I.). After 24 and 48 h, the capacity of Ad.hNGF to transduce RNCMs was determined by RT-PCR for human NGF, western blot for the V5 Tag on RNCM lysates or RNCM CCM, and by NGF ELISA (Promega) of the RNCM CCM. In a supplementary experiment, at 24 h from infection, RNCMs were incubated with AngII (10 À7 M) for 24 h or submitted to 12 h hypoxia and 12 h reoxygenation before being analyzed by RT-PCR for human NGF cDNA level or western blot for V5 (both cell lysated and CCM).
In vitro TUNEL assay of RNCMs. Cells were cultured in gelatin-coated Labtekt slides (Nalge Nunc Int.) and fixed with 4% paraformaldehyde (PFA, 10 min, RT). Endogenous peroxidase activity was quenched with 3% H 2 O 2 in methanol (5 min, RT). TUNEL assay was performed according to the manufacture's instruction (Calbiochem). Nuclei were counterstained with methyl green dye.
Hypoxia/reoxygenation and AngII apoptosis assays on RNCMs. Following infection with Ad.NGF or Ad.bGal, apoptosis of serum-freecultured RNCMs was induced by two methods: (1) cells were transferred to an anaerobic chamber which was purged with 95% N 2 /5% CO 2 . RNCMs were kept under hypoxia for 12 h before being reoxygenated under normoxic conditions for 24 h. Incubations were performed at 371C 19 or (2) cells were incubated with AngII (10 À7 M) for 24 h. 20 Apoptosis was detected by both cleaved caspase 3 staining and TUNEL assay. At least 800 RNCMs (in eight randomly chosen Â 400 fields from three independent experiments) were scored in a blinded fashion to calculate the percentage of cleaved caspase 3-positive or TUNEL-positive nuclei. Data are expressed as the average percentage of apoptotic cells or nuclei.
Apoptosis assays in the presence of K252a, LY294002, Ad.DN-Akt, or Ad.AAA Foxo-3a. Adenoviruses carrying a dominant negative form of Akt (Ad.DN-Akt) 3 and a constitutive active mutant form of Foxo-3a which has Alanine residues in the three phosphorylation sites of Akt and is consequently resistant to Akt phosphorylation (Ad.AAAFoxo3a) (Vector Biolabs, Philadelphia, PA, USA) were used for this experiment. RNCMs were coinfected with Ad.NGF or Ad.bGal (50 m.o.i) plus Ad.DN-Akt, Ad.AAAFoxo3a, or Ad.bGal (the latter as control of either Ad.DN-Akt or Ad.AAAFoxo3a) (100 M.O.I.). After 24 h from infection, serum-freecultured RNCMs underwent 5 h hypoxia/ 24 h reoxygenation. In separate experiments, RNCMs were infected with Ad.NGF or Ad.bGal and, after 24 h, treated with the PI3K inhibitor LY294002 (Sigma-Aldrich, 50 mM), the trkA inhibitor K252a (Sigma-Aldrich, 100 nM), or their vehicle (0.1% DMSO) starting 30 min before undergoing 5 h hypoxia/24 h reoxygenation. Apoptosis was evaluated by both cleaved caspase-3 staining and by TUNEL assay. Data are expressed as the average percentage of apoptotic myocytes and nuclei, respectively. For reference, additionally experiments were performed treating RNCMs as described above, but maintaining them under normoxia.
RNCM transfection with siRNA and apoptosis assay. RNCM were plated on gelatin-coated 12-well plate and transfected (using Oligofectaminet, Invitrogen) with Akt siRNA (50 nM, SignalSilence @ Akt siRNA, # 6211 Cell Signaling), which targets both Akt1 and Akt2, or negative control scramble siRNA. Knockdown of Akt protein at 48 h following Akt siRNA transfection was confirmed by western blotting. Following transfection, RNMCs were infected with Ad.NGF or Ad.bGal (50 m.o.i each). After 24 h from infection, RNCMs underwent 5 h hypoxia/ 24 h reoxygenation or were maintained under normoxia (for 29 h). Apoptosis was evaluated by both cleaved-caspase 3 and TUNEL assay, as described above.
In vitro TUNEL assay of rat adult myocytes. Cells were cultured in laminin-coated Labtekt slides (Nalge Nunc Int.) and fixed with 4% paraformaldehyde (PFA, 10 min, RT). TUNEL assay was performed according to the manufacture's instruction (Calbiochem). Then, the same sections were stained with a mouse monoclonal primary antibody for a-sarcomeric actin (Sigma, 1 : 30, 16 h, 41C) followed by secondary antibody rabbit anti-mouse TRITC (1 : 20,1 h, RT, Sigma). Nuclei were counterstained with DAPI (Sigma).
H/R and AngII apoptosis assays on rat adult cardiomyocytes. H/R (6 h hypoxia, 18 h reoxygenation) was performed accordingly to Kang et al. 24 Apoptosis was detected by both cleaved-caspase 3 staining and TUNEL assay. Cardiomyocytes were stained by an antibody for a-sarcomeric actin. Cells were examined at Â 400 magnification. Cleaved-caspase-3-positive or TUNEL-positive cells were scored in a blinded fashion in eight randomly chosen fields from three independent experiments. Data are expressed as the average percentage of apoptotic cells. AngII apoptosis assay was performed as previously reported. 23 Isolated rat adult cardiac myocytes were treated with AngII (10 À9 M) in the presence of recombinant NGF (50ng/ml) or PBS for 24 h. Also in this case, apoptosis was evaluated by both cleaved-caspase 3 staining and TUNEL assay.
Rat myocardial infarct and intra-myocardial NGF gene transfer. Wistar rats (Charles River, Calco, Italy) were anesthetized by ketamine chloride (40 mg/kg i.p., Merial, Milan, Italy) plus medetomidine hydrochloride (0.15 mg/kg i.p., Pfizer Italia srl, Latina, Italy) and artificially ventilated. Myocardial infarct was induced by permanent ligature of the left coronary artery. After 3 min of coronary ligation, Ad.NGF or Ad.bGal (each at 10 8 p.f.u.) was injected into four adjacent points of the MI border zone. At 3 days postsurgery, the heart of anaesthetized rats (n ¼ 3 per group) was harvested and processed for RNA extraction. Other rats (n ¼ 7 per group) were killed at 7 days post-MI by arresting the heart by intraventricular injection of cadmium chloride. Hearts were perfusion/fixed with buffered formalin and embedded in paraffin. Heart sections were submitted to V5 immunohistochemistry and TUNEL apoptosis assay (vide infra).
V5 immunohistochemistry of heart sections. Heart sections were incubated with rabbit serum to block aspecific binding and then with a goat-raised primary antibody for V5 (1 : 100, 16 h, 41C, Novus Biologicals), followed by a secondary antibody rabbit anti-goat FITC (1 : 20, 1 h, 371C, Sigma). Then, sections were blocked with rabbit serum and stained with a-sarcomeric actin (monoclonal mouse, 1 : 30, 16 h, 41C, Sigma), followed by secondary antibody rabbit anti-mouse TRITC (1 : 20,1 h, 371C, Sigma). Nuclei were counterstained with DAPI (Sigma). Sections were analyzed with a fluorescent microscope.
TUNEL assay on rat heart sections. Sections (4 mm) of rat hearts were cut and mounted on slides. Following treatment of slides with xylene, graded alcohol, and H 2 O, endogenous peroxidase activity was quenched with 3% H 2 O 2 in methanol (30 min, RT). TUNEL assay was performed according to the manufacture's instruction (Calbiochem). The same sections were then stained with a mouse monoclonal primary antibody for the myocyte marker a-sarcomeric actin (Sigma, 1 : 30, 16 h, 41C), which was revealed by VIP kit (Vector Laboratories).
The numbers of TUNEL-positive apoptotic cardiomyocytes in the peri-infarct myocardium was counted with the aid of ocular reticle, at Â 1000 magnification. The density of apoptotic cardiomyocytes per mm 2 of tissue section was calculated. 32, 33 Statistics. Values are presented as mean7S.E.M. Analyses were performed using the SigmaStat 3.1 software. Statistical significance was evaluated by use of unpaired t-test for comparison between two groups. For comparison among more than two groups, ANOVA was used, followed by unpaired t-test. A P-value o0.05 was interpreted to denote statistical significance.
